N-acetylcysteine was well tolerated : 146 ( 29 % ) of 495 patients who received at least one dose of N-acetylcysteine had adverse events ( 48 serious ) , as did 130 ( 26 % ) of 495 patients who received at least one dose of placebo ( 46 serious ) .